Asclera
- Product NDC
- 67850-140
- 11-digit product format
- 678500140
- Labeler code
- 67850
- Product ID
- 67850-140_f443bbaf-ef8e-4f9e-ba4c-6f87dc58a671
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- POLIDOCANOL
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Methapharm, Inc
- Application
- NDA021201
- Marketing category
- NDA
- Marketing start
- 2010-06-01
- Substance
- POLIDOCANOL
- Active strength
- .005 g/mL
- Pharmacologic classes
- Sclerosing Activity [MoA], Sclerosing Agent [EPC], Vascular Sclerosing Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Asclera
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| POLIDOCANOL | .005 g/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 0AWH8BFG9A |
| Rxcui | 968173, 968177, 968181, 968183 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 67850-140-05 | Asclera | 2 mL in 1 AMPULE | INJECTION, SOLUTION | 2 | | 26 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 67850-140 | ASCLERA (POLIDOCANOL) INJECTION, SOLUTION [METHAPHARM, INC] | 25 | Current NDC, Legacy NDC, 1 package rows | 20250117_bb1f342b-5352-4059-a0b2-e60fd652fd28.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 67850-140-05 | 67850014005 | 2 mL in 1 AMPULE (67850-140-05) | 2 ml | 2022-02-01 | 0000-00-00 | No | No | Current |